Research location
Varanasi
Uttar Pradesh, India
Advertisement
Research activity in Varanasi
Uttar Pradesh, IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 42 trials and 46 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Varanasi
42 linked trials · page 1 of 1A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionNCT07063745 · 2026-01-02 · 1 site observation
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)NCT06937229 · 2025-12-02 · 1 site observation
RECRUITING
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)NCT06926868 · 2025-09-11 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseNCT06976216 · 2025-07-14 · 1 site observation
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)NCT07011732 · 2025-07-10 · 1 site observation
RECRUITING
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)NCT06875310 · 2025-04-24 · 1 site observation
RECRUITING
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).NCT06646276 · 2025-02-25 · 1 site observation
RECRUITING
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%NCT06561386 · 2024-10-07 · 1 site observation
RECRUITING
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With ChemotherapyNCT06926543 · 2024-05-14 · 1 site observation
RECRUITING
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)NCT05348876 · 2022-08-03 · 1 site observation
RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
A Clinical Trial of an Herbal Liquid Supplement - 'DBPS' for Managing Blood PressureNCT07629570 · 2026-05-15 · 4 site observations
NOT_YET_RECRUITING
A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.NCT06496893 · 2024-09-12 · 2 site observations
COMPLETED
NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer PatientsNCT06131424 · 2024-04-23 · 1 site observation
COMPLETED
Doxil/Caelyx BE StudyNCT05567601 · 2023-12-16 · 1 site observation
COMPLETED
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyNCT05645536 · 2022-12-28 · 1 site observation
ENROLLING_BY_INVITATION
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.NCT05445843 · 2022-12-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.NCT05110196 · 2022-09-03 · 1 site observation
COMPLETED
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionNCT05022004 · 2021-12-20 · 1 site observation
COMPLETED
Mortality of Cancer Surgery During SARS CoV2 PandemicNCT05240378 · 2021-10-29 · 1 site observation
COMPLETED
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) MetastasesNCT04603807 · 2021-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderNCT04985942 · 2021-07-30 · 1 site observation
COMPLETED
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerNCT04906395 · 2021-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
of Androgen Receptor Expression in Breast Cancer With or Without BRCA MutationNCT05404334 · 2021-07-01 · 1 site observation
COMPLETED
Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in IndiaNCT04288895 · 2020-02-20 · 1 site observation
COMPLETED
A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in IndiaNCT04153981 · 2019-12-16 · 1 site observation
COMPLETED
Indian Phenotype RegistryNCT03363594 · 2017-12-11 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With AsthmaNCT02892344 · 2017-01-16 · 1 site observation
COMPLETED
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesNCT02963766 · 2016-12-29 · 1 site observation
COMPLETED
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusNCT02773368 · 2016-05-23 · 1 site observation
COMPLETED
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminNCT01519674 · 2012-06-01 · 1 site observation
COMPLETED
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaNCT01412060 · 2011-09-27 · 1 site observation
COMPLETED
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaNCT01149655 · 2011-07-01 · 1 site observation
COMPLETED
Relapse Prevention Study in Patients With SchizophreniaNCT01291511 · 2011-02-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01255787 · 2010-11-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)NCT01111539 · 2010-07-13 · 1 site observation
TERMINATED
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.NCT01122927 · 2010-07-01 · 1 site observation
TERMINATED
Safety and Efficacy of Cariprazine in SchizophreniaNCT01104779 · 2010-04-27 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer PatientsNCT00772824 · 2007-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.